• The I148M variant of PNPLA3 associated with NAFLD severity. It increases risk of developing NASH, advanced fibrosis and cirrhosis.146 This has been observed in the Japanese, Italians, Malaysians and Americans147-151 populations. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.